Effectiveness of High-dose Three-dimensional Conformal Radiotherapy in Hepatocellular Carcinoma with Portal Vein Thrombosis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Rim, Chai Hong | - |
dc.contributor.author | Yang, Dae Sik | - |
dc.contributor.author | Park, Young Je | - |
dc.contributor.author | Yoon, Won Sup | - |
dc.contributor.author | Lee, Jung Ae | - |
dc.contributor.author | Kim, Chul Yong | - |
dc.date.accessioned | 2021-09-06T17:26:19Z | - |
dc.date.available | 2021-09-06T17:26:19Z | - |
dc.date.created | 2021-06-18 | - |
dc.date.issued | 2012-08 | - |
dc.identifier.issn | 0368-2811 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/107874 | - |
dc.description.abstract | To evaluate the treatment outcome of three-dimensional conformal radiotherapy in hepatocellular carcinoma patients with portal vein thrombosis, concerning survival and treatment response of thrombosis. Forty-five patients with hepatocellular carcinoma who had portal vein thrombosis treated from March 2005 to March 2011 were the subjects of this study. The median total dose was 61.2 Gy (range 3865 Gy). A daily radiation dose of 1.82.5 Gy was administered at a frequency of five fractions per week. The clinical target volume included portal vein thrombosis with or without primary tumour with clinical consideration. Three of the 45 patients (6.7) showed complete remission of portal vein thrombosis, 25 patients (55.6) showed partial response, 14 patients (31) had stable disease and 3 patients (6.7) had progressive disease. The median and the 1-year survival rate of the responders (complete remission progressive disease) were 16.7 months and 63.7, respectively, and those of the non-responders were 8 months and 28.2, respectively (P 0.003). A univariate analysis revealed that thrombosis response, Eastern Cooperative Oncology Group performance status, maximum tumour size, tumour bilaterality, Cancer of the Liver Italian Program stage, Okuda stage, hepatic arterial infusion, hepatitis B oe' antigen and hepatitis C antibody were statistically significant prognostic factors affecting survival. In a multivariate analysis, thrombosis response, Cancer of the Liver Italian Program stage and Okuda stage were found to be statistically significant. No clinically significant radiation-induced liver disease was noted. One grade 3 late complication (duodenal ulcer) was reported. High-dose three-dimensional conformal radiotherapy yielded a response rate of 62.3. It is a safe and effective treatment prolonging the survival of hepatocellular carcinoma patients with portal vein thrombosis. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | OXFORD UNIV PRESS | - |
dc.subject | TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION | - |
dc.subject | RADIATION-THERAPY | - |
dc.subject | TUMOR THROMBOSIS | - |
dc.subject | INVASION | - |
dc.subject | TRIALS | - |
dc.subject | DESIGN | - |
dc.title | Effectiveness of High-dose Three-dimensional Conformal Radiotherapy in Hepatocellular Carcinoma with Portal Vein Thrombosis | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Rim, Chai Hong | - |
dc.contributor.affiliatedAuthor | Yang, Dae Sik | - |
dc.contributor.affiliatedAuthor | Yoon, Won Sup | - |
dc.contributor.affiliatedAuthor | Kim, Chul Yong | - |
dc.identifier.doi | 10.1093/jjco/hys082 | - |
dc.identifier.scopusid | 2-s2.0-84865065318 | - |
dc.identifier.wosid | 000306969900008 | - |
dc.identifier.bibliographicCitation | JAPANESE JOURNAL OF CLINICAL ONCOLOGY, v.42, no.8, pp.721 - 729 | - |
dc.relation.isPartOf | JAPANESE JOURNAL OF CLINICAL ONCOLOGY | - |
dc.citation.title | JAPANESE JOURNAL OF CLINICAL ONCOLOGY | - |
dc.citation.volume | 42 | - |
dc.citation.number | 8 | - |
dc.citation.startPage | 721 | - |
dc.citation.endPage | 729 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.subject.keywordPlus | TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION | - |
dc.subject.keywordPlus | RADIATION-THERAPY | - |
dc.subject.keywordPlus | TUMOR THROMBOSIS | - |
dc.subject.keywordPlus | INVASION | - |
dc.subject.keywordPlus | TRIALS | - |
dc.subject.keywordPlus | DESIGN | - |
dc.subject.keywordAuthor | hepatocellular carcinoma | - |
dc.subject.keywordAuthor | portal vein thrombosis | - |
dc.subject.keywordAuthor | radiotherapy | - |
dc.subject.keywordAuthor | high-dose | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.